Avalide

Avalide is out, replaced by Avapro, which is the same stuff without the diuretic.

Shoes—and ships—and sealing wax— superversive 2007

Combined sales of blood-pressure drugs Avapro and Avalide tumbled 23% to $195 million.

Bristol-Myers Net Rises 76% on Lower Taxes Peter Loftus 2012

Bristol said Thursday that the supply of Avalide could be interrupted for an extended time.

Bristol-Myers Profit Falls on Prior-Year Asset Gain Peter Loftus 2011

Combined sales of hypertension drugs Avapro and Avalide, which are also due to lose patent protection in 2012, fell 26% to $252 million.

Bristol-Myers Profit Falls on Prior-Year Asset Gain Peter Loftus 2011

Bristol and Sanofi recently recalled about 64 million tablets of Avalide in the U.S., Canada and some other markets because a manufacturing problem could affect the drug's efficacy.

Bristol-Myers Profit Falls on Prior-Year Asset Gain Peter Loftus 2011

Earlier this year, Bristol and Sanofi recalled about 64 million Avalide tablets because a manufacturing problem.

Bristol-Myers Profit Rises 33% as Sales Improve Thomas Gryta 2011

Virology drugs Reyataz, Sustiva and Baraclude posted sales gains, while sales of anti-hypertension drugs Avapro and Avalide declined.

Bristol-Myers Profit Slips Peter Loftus 2010

Bristol-Myers and marketing partner Sanofi have recalled certain lots of Avalide over the past year due to manufacturing-quality problems.

Bristol-Myers Net Falls, but Plavix Sales Are Up Peter Loftus 2011

Combined sales of hypertension drugs Avapro and Avalide, which are also due to lose patent protection next year, fell 8% to $290 million.

Bristol-Myers Profit Rises 33% as Sales Improve Thomas Gryta 2011

Combined sales of blood-pressure treatments Avapro and Avalide dropped 18% to $251 million.

Bristol-Myers Net Falls, but Plavix Sales Are Up Peter Loftus 2011